SCHEMBL338622

SCHEMBL338622

c1ccc(-c2ccc(-c3ccc(-c4nc(-c5ccc(-c6ccc(-c7ccccc7)cc6)cc5)nc(-c5ccc(-c6ccc(-c7ccccc7)cc6)cc5)n4)cc3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.67
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
ALDH1A1 P00352 4/20 0.60
MAPT P10636 2/20 0.60
HPGD P15428 2/20 0.60
ADORA2A P29274 2/20 0.59
ADORA1 P30542 2/20 0.59
POLB P06746 1/20 0.59
ADORA3 P0DMS8 1/20 0.59
ADORA2B P29275 1/20 0.59
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
MAPK1 P28482 2/20 0.58
CYP3A4 P08684 1/20 0.55
TAAR1 Q96RJ0 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
NFKB1 P19838 2/20 0.55
NFKB2 Q00653 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18270369 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13492073 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL15894213 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL2876356 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18212400 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18270370 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23608941 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL19543731 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL15894206 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL12636103 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023139038-A1 UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES BASF SE (DE) 2023-07-27 WO disclosed
WO-2023139037-A1 UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES BASF SE (DE) 2023-07-27 WO disclosed
US-11666050-B2 Enhancing the antimicrobial activity of biocides with polymers BASF SE (DE) 2023-06-06 US disclosed
US-11647746-B2 Enhancing the antimicrobial activity of biocides with polymers BASF SE (DE) 2023-05-16 US disclosed
US-20220183934-A1 SUNSCREEN COMPOSITIONS CONTAINING POROUS METAL OXIDE SPHERES BASF SE (DE) 2022-06-16 US disclosed
EP-3481365-B1 SOLUBILIZING AGENTS FOR UV FILTERS IN COSMETIC FORMULATIONS BASF SE (DE) 2021-09-08 EP disclosed
EP-3769624-A2 ENHANCING THE ANTIMICROBIAL ACTIVITY OF BIOCIDES WITH POLYMERS BASF SE (DE) 2021-01-27 EP disclosed
EP-2817353-B1 ENHANCING THE ANTIMICROBIAL ACTIVITY OF BIOCIDES WITH POLYMERS BASF SE (DE) 2021-01-13 EP disclosed
WO-2020182936-A1 SUNSCREEN COMPOSITIONS CONTAINING POROUS METAL OXIDE SPHERES BASF SE (DE) 2020-09-17 WO disclosed
US-20200221694-A1 Enhancing the Antimicrobial Activity of Biocides with Polymers BASF SE (DE) 2020-07-16 US disclosed
US-20100039026-A1 Organic light emitting diode employing luminescent efficiency improvement layer SAMSUNG DISPLAY CO., LTD. (KR) 2010-02-18 US disclosed
US-20090214453-A1 Use of Transmission Dyes for Protecting Human Skin From Browning and Ageing BASF SE (DE) 2009-08-27 US disclosed
US-20090196894-A1 Self Tanning Composition CIBA CORP. 2009-08-06 US disclosed
US-20090102373-A1 Electroluminescent device HAYOZ PASCAL 2009-04-23 US disclosed
US-20090102373-A1 Electroluminescent device HAYOZ PASCAL 2009-04-23 US disclosed
WO-2009027390-A2 STABILIZATION OF COSMETIC COMPOSITIONS BASF SE (CH) 2009-03-05 WO disclosed
US-7311897-B2 Triazines which are symmetrically substituted by phenyl, biphenyl, triphenyl or naphthyl can be used as highly effective UV absorbers for cosmetic applications CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-12-25 US disclosed
US-7311897-B2 Triazines which are symmetrically substituted by phenyl, biphenyl, triphenyl or naphthyl can be used as highly effective UV absorbers for cosmetic applications CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-12-25 US disclosed
US-20070104662-A1 Ultraviolet ray absorbing composite powder IWASE COSFA CO., LTD. (JP) 2007-05-10 US disclosed
EP-1782792-A1 Ultraviolet ray absorbing composite powder Iwase Cosfa Co., Ltd. (JP) 2007-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220183934-A1 SUNSCREEN COMPOSITIONS CONTAINING POROUS METAL OXIDE SPHERES SDHB, SDHA, MCM5 L3MBTL1 4851/4885MEN1 759/4885KMT2A 2209/4885
US-20090196894-A1 Self Tanning Composition C9, KRT18, F12 L3MBTL1 2250/4885MEN1 2751/4885KMT2A 992/4885
US-20090214453-A1 Use of Transmission Dyes for Protecting Human Skin From Browning and Ageing CUTA, TYR, GLA L3MBTL1 2434/4885MEN1 1116/4885KMT2A 4124/4885
US-11647746-B2 Enhancing the antimicrobial activity of biocides with polymers CAT, AOC1, DDT L3MBTL1 4118/4885MEN1 4238/4885KMT2A 1182/4885
US-20070104662-A1 Ultraviolet ray absorbing composite powder XRCC5, XRCC6, ERCC1 L3MBTL1 3789/4885MEN1 2195/4885KMT2A 4136/4885
US-11666050-B2 Enhancing the antimicrobial activity of biocides with polymers CAT, AOC1, DDT L3MBTL1 4118/4885MEN1 4238/4885KMT2A 1182/4885
US-20200221694-A1 Enhancing the Antimicrobial Activity of Biocides with Polymers CAT, AOC1, DDT L3MBTL1 4118/4885MEN1 4238/4885KMT2A 1182/4885
US-20090102373-A1 Electroluminescent device TAAR5, TYR, TRPC5 L3MBTL1 1776/4885MEN1 1125/4885KMT2A 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.